Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 4/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.31 |
| ▸ | CA2 | P00918 | 4/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | MMP9 | P14780 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28776609 | 1.00 | THRB (0.43) | THRBMEN1KMT2AGRM5GRM1 | |
| SCHEMBL1031356 | 1.00 | THRB (0.43) | THRBMEN1KMT2AGRM5GRM1 | |
| SCHEMBL1031354 | 1.00 | THRB (0.43) | THRBMEN1KMT2AGRM5GRM1 | |
| SCHEMBL1920420 | 0.95 | THRB (0.36) | THRBMEN1KMT2AGRM5GRM1 | |
| SCHEMBL1920419 | 0.95 | THRB (0.36) | THRBMEN1KMT2AGRM5GRM1 | |
| SCHEMBL524807 | 0.95 | THRB (0.36) | THRBMEN1KMT2AGRM5GRM1 | |
| Heptane SCHEMBL28774909 | 0.84 | NAAA (0.40) | EPHX1 | |
| SCHEMBL27769894 | 0.81 | TSHR (0.38) | GRM5GRM1CA1CA2CA12 | |
| Sulfuric Acid SCHEMBL10598950 | 0.78 | THRB (0.62) | THRBMEN1KMT2ACA1CA2 | |
| Sulfuric Acid SCHEMBL3383145 | 0.78 | THRB (0.62) | THRBMEN1KMT2ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111323497-B | Optical purity analysis method of pasireotide starting material | 武汉武药科技有限公司 | 2022-07-12 | — | — | CN | claimed |
| US-20250177330-A1 | Use of Thiol Compounds to Treat Neurological Disease | MERCAPTOR DISCOVERIES, INC. | 2025-06-05 | — | — | US | disclosed |
| US-12128014-B2 | Use of thiol compounds to treat neurological disease | MERCAPTOR DISCOVERIES, INC. (US) | 2024-10-29 | — | — | US | disclosed |
| EP-3615013-B1 | THIOL COMPOUNS FOR TREATING ACUTE TRAUMATIC BRAIN INJURY | MERCAPTOR DISCOVERIES INC (US) | 2024-08-14 | — | — | EP | disclosed |
| US-20230115413-A1 | Use of Thiol Compounds to Treat Neurological Disease | ZANKEL, TODD C, MR | 2023-04-13 | — | — | US | disclosed |
| CN-111323497-B | Optical purity analysis method of pasireotide starting material | 武汉武药科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-10265644-B2 | Enantioselective zwitterionic ion-exchange material | UNIVERSITAET WIEN (AT) | 2019-04-23 | — | — | US | disclosed |
| US-10265644-B2 | Enantioselective zwitterionic ion-exchange material | UNIVERSITAET WIEN (AT) | 2019-04-23 | — | — | US | disclosed |
| EP-2276567-B1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIV WIEN (AT) | 2019-04-10 | — | — | EP | disclosed |
| EP-2276567-B1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIV WIEN (AT) | 2019-04-10 | — | — | EP | disclosed |
| US-20110121229-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIVERSITAET WIEN (AT) | 2011-05-26 | — | — | US | disclosed |
| CN-102066003-A | Enantioselective zwitterionic ion-exchanee material | UNIV WIEN | 2011-05-18 | — | — | CN | disclosed |
| EP-2276567-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANEE MATERIAL | Universität Wien (AT) | 2011-01-26 | — | — | EP | disclosed |
| CN-101255126-B | Preparation of taurine and derivatives thereof | UNIV BEIJING | 2010-12-01 | — | — | CN | disclosed |
| CN-101148427-B | Method for preparing substituted taurine | UNIV BEIJING | 2010-10-27 | — | — | CN | disclosed |
| WO-2009137853-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANEE MATERIAL | Universität Wien (AT) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009137853-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANEE MATERIAL | Universität Wien (AT) | 2009-11-19 | — | — | WO | disclosed |
| CN-101337914-A | Method for preparing taurine and substituted taurine | UNIV BEIJING CHEMICAL (CN) | 2009-01-07 | — | — | CN | disclosed |
| CN-101255126-A | Preparation of taurine and derivatives thereof | UNIV BEIJING (CN) | 2008-09-03 | — | — | CN | disclosed |
| CN-101148427-A | Method for preparing substituted taurine | UNIV BEIJING (CN) | 2008-03-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12128014-B2 | Use of thiol compounds to treat neurological disease | TST, NLN, SLC7A11 | THRB 2362/4885MEN1 4798/4885KMT2A 3488/4885 |
| US-20230115413-A1 | Use of Thiol Compounds to Treat Neurological Disease | TST, NLN, SLC7A11 | THRB 2362/4885MEN1 4798/4885KMT2A 3488/4885 |
| US-20250177330-A1 | Use of Thiol Compounds to Treat Neurological Disease | TST, NLN, SLC7A11 | THRB 2362/4885MEN1 4798/4885KMT2A 3488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.